MedPath

Women At Risk: The High Risk Breast Cancer Program

Conditions
Breast Cancer
Registration Number
NCT01034891
Lead Sponsor
New York Presbyterian Hospital
Brief Summary

The purpose of this study is to increase understanding of women who are at high risk for developing breast cancer. Data from this group will be collected and entered into a registry. This registry serves as a clinical database to support research in prevention, early detection and treatment of breast cancer.

Detailed Description

This is a longitudinal cohort study that collects data of eligible women at risk for developing breast cancer. Patient information will be entered into a secured computerized database that is used for research on the prevention, early detection and treatment of breast cancer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
2000
Inclusion Criteria
  • one or more first-degree relatives (mother, daughter, or sister) with pre-menopausal breast cancer
  • two or more first-degree relatives with post-menopausal breast cancer
  • tested positive for a BRCA1 or BRCA2 mutation
  • a history of biopsy-proven atypical ductal hyperplasia or atypical lobular hyperplasia
  • a history of biopsy-proven lobular neoplasia (lobular carcinoma in situ)
Exclusion Criteria
  • DCIS (ductal carcinoma in situ)
  • previous diagnosis of breast cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Women At Risk, Weill Cornell

🇺🇸

New York, New York, United States

Women At Risk, Columbia University Medical Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath